Trendlines Group
Signal active
Investment Firm
Overview
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag Innovation Fund.
The company was founded in 1993 and is headquartered in Misgav, Israel.
Highlights
Founded
1993
Industry
Angel Investment
Employees
51-100
Investment
59
Lead Investment
13
Exits
11
Stages
Early Stage Venture, Seed, Late Stage Venture
Investor Type
Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Trendlines Group, established in 1993 and headquartered in Asia., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Biotechnology, Health Care, Medical, Medical Device, Financial Services, Venture Capital, Finance, Therapeutics, Angel Investment, Life Science. The organization boasts a portfolio of 59 investments, with an average round size of $6.1M and 11 successful exits. Their recent investments include Nephera, Evergreen Venture Partners, Immunovative Therapies, Polytouch Medical, Mass Medical Angels. The highest investment round they participated in was $11.7B. Among their most notable exits are Nephera and Evergreen Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Trendlines Group has made 59 investments. Their most recent investment was on Apr 09, 2024, when Peptobiotics raised $6.2M.
investments
59
Diversity investments
0
Lead investments
13
Number of exits
11
Investments
59
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 28, 2023 | Insectta | Biotechnology | 1.0M |
| Sep 05, 2023 | - | - | 8.3M |
| Apr 09, 2024 | Peptobiotics | Biotechnology | 6.2M |
| Jun 11, 2024 | AgriG8 | Financial Services | null |
Exits
11
Funding Timeline
Funding rounds
59
Investors
1
Funds
1
Funding Rounds
59
Trendlines Group has raised 59 rounds. Their latest funding was raised on Jun 11, 2024 from a Venture Round - AgriG8 round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 28, 2023 | Venture Round - Insectta | - | 1.0M | - |
| Sep 05, 2023 | Venture Round - ViAqua Therapeutics | - | 8.3M | - |
| Apr 09, 2024 | Series A - Peptobiotics | - | 6.2M | - |
| Jun 11, 2024 | Venture Round - AgriG8 | - | 0 | - |
Investors
10
Trendlines Group is funded by 10 investor(s). Librae Holdings Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Post-IPO Equity - Trendlines Group | 9.8M |
Librae Holdings | Yes | Post-IPO Equity - Trendlines Group | 8.0M |
| - | No | Post-IPO Equity - Trendlines Group | 18.4M |
| - | No | Post-IPO Equity - Trendlines Group | 15.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.